Prophylactic Use

Prophylactic Use is a clinical intervention strategy involving the administration of tranexamic acid prior to the onset of hemorrhagic risk to prevent excessive bleeding, distinguished from therapeutic use by its preemptive timing and intent to avert pathology rather than treat established bleeding.

2K

Publications

114.5K

Citations

10.2K

Authors

2.7K

Institutions

Publications per year

2017–2026

422

Authors

10.2K

  1. KF
    Kathelijn Fischer

    University Medical Center Utrecht, Netherlands

    15 publications · 1.6K citations

    14

    h-index

  2. GH
    Gary H. Lyman

    Fred Hutch Cancer Center, United States

    11 publications · 802 citations

    11

    h-index

  3. RL
    Rolf Ljung

    Lund University, Sweden

    11 publications · 930 citations

    11

    h-index

  4. CD
    Catherine Deneux‐Tharaux

    Inserm, France

    9 publications · 998 citations

    9

    h-index

  5. PP
    Pia Petrini

    Karolinska University Hospital, Sweden

    8 publications · 906 citations

    8

    h-index

1–5 of 10.2K

Venues

  1. PubMed

    Repository · 193 publications · 6.4K citations

    39

    h-index

  2. Haemophilia

    72 publications · 4.2K citations

    37

    h-index

  3. New England Journal of Medicine

    NEJM · 29 publications · 17K citations

    26

    h-index

  4. Anesthesia & Analgesia

    20 publications · 1.3K citations

    20

    h-index

  5. JAMA

    23 publications · 1.8K citations

    17

    h-index

1–5